Mindful Health Solutions
United StatesFounded 2007
- Neuromodulation
- Depression
Mindful Health Solutions is an outpatient psychiatric care provider specializing in treatment-resistant depression and other mental health conditions. Its clinicians offer personalized care that combines medication management with interventional treatments such as TMS, SPRAVATO (esketamine), and IV ketamine across clinics in California, Texas, and Washington.
- Open roles
- 13
- Posted last 30 daysPosted in the last 30 days
- 10
- RaisedTotal raised
- $5.4M
- Investors
- 3
- Founded
- 2007
reccy insights
On Aug 20, 2026, Radial announced its acquisition of Mindful Health Solutions. The announcement positions the company within a broader brain-medicine clinical network; related coverage described a 27-clinic network with more than 100 clinicians. The acquisition is a major ownership and scale milestone, although no transaction value was disclosed. In 2025, Mindful Health Solutions announced a collaboration with Sohar Health to use its verification solution to support the patient experience. The company was also reported to be hiring psychiatrists and medical directors during 2025. Earlier, on Oct 1, 2024, it announced a CEO hire from the PE-backed dental-services sector; Meghan Herwehe is listed as CEO, with a 2024 start date. The company’s clinical offering includes TMS, SPRAVATO (esketamine), ketamine infusion therapy, and medication management. Taken together, the acquisition and operational announcements point to continued expansion of a specialized outpatient psychiatry model, while available public information does not disclose the acquisition terms or quantified operating results.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
Open roles13
10 roles posted in the last 30 days
Open roles by the month Mindful Health Solutions posted them
- 00Jun
- 00Jul
- 00Aug
- 00Sep
- 99Oct
- 33Nov
Psychiatrists and medical directors.
Actively hiring psychiatrists and medical directors, with multiple new-hire announcements during 2025.
- Posted 3d ago
Interventional Psychiatric Technician
Spartanburg, SC · Mid · Posted 3d ago
- Posted 9d ago
General Counsel
Hybrid (New york, New York, US) · Mid · Posted 9d ago
- Posted 10d ago
Patient Care Technician
Oakland, CA · Mid · Posted 10d ago
- Posted 14d ago
Head of Provider Partnerships
Remote (US) · Director · Posted 14d ago
- Posted 15d ago
Provider Partner Manager
Chattanooga, TN · Manager · Posted 15d ago
What makes Mindful Health Solutions distinct
- 01Specializes in treatment-resistant depression and interventional psychiatry.
- 02Combines TMS, SPRAVATO (esketamine), and IV ketamine with medication management and telepsychiatry.
- 03Operates 21 outpatient clinics across California, Texas, and Washington.
- 04Uses clinical outcomes from more than 50,000 patients and 300,000 visits to inform care and treatment-outcome prediction.
- 05Supports patients with insurance benefits, pre-authorization, and financing.
Technology & products4
- Transcranial Magnetic Stimulation (TMS)
A non-invasive procedure using magnetic pulses to stimulate brain regions involved in mood regulation, primarily for treatment-resistant depression and other psychiatric conditions.
- SPRAVATO (Esketamine)
An FDA-approved nasal spray medication for patients with depression unresponsive to traditional antidepressants, designed to reduce depressive symptoms by promoting new neural connections.
- Ketamine Infusion Therapy
An intravenous treatment intended to provide rapid improvement in symptoms of treatment-resistant depression, PTSD, and other psychiatric conditions.
+ 1 more: General Medication Management
In the Cortex
- BrainsWay partners with Mindful Health Solutions networkInvesting.com South Africa · Nov 2, 2026
Funding
- Venture RoundJan 2024
- Venture RoundOct 2021CIBC Innovation Banking, Norwest
- Venture RoundOct 2017$5.4M
Similar companies
About Mindful Health Solutions
- Products
- Transcranial Magnetic Stimulation (TMS), SPRAVATO (Esketamine), Ketamine Infusion Therapy, General Medication Management
- Leadership
- Ara Chackerian, Co-Founder and Board MemberBrad Hummel, Co-Founder, Board MemberRichard Bermudes, Chief Medical OfficerMeghan Herwehe, CEO
- Focus areas
- Mental health, psychiatry, treatment-resistant depression, transcranial magnetic stimulation, esketamine, ketamine therapy, outpatient care, telepsychiatry
- Headquarters
- United States
- Founded
- 2007
- Employees
- 101–250